about
Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort studyCombining GFR and albuminuria to classify CKD improves prediction of ESRD.Microalbuminuria screening for detecting chronic kidney disease in the general population: a systematic review.Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled studyCystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA)Renal gene and protein expression signatures for prediction of kidney disease progressionCirculating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population.Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human.A risk score for chronic kidney disease in the general populationA system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.Kidney function and risk triage in adults: threshold values and hierarchical importance.Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolAssociation of short sleep duration and rapid decline in renal function.Health effects of protein intake in healthy adults: a systematic literature review.Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunctionCardiovascular disease in chronic kidney disease.Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome, and chronic kidney disease in Taiwanese.Health effects of protein intake in healthy elderly populations: a systematic literature review.A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations.Renal function and target organ damage in hypertension.Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.New renal drug development to face chronic renal disease.Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.Serum tryptase concentration and progression to end-stage renal disease.A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome.Genetic risk prediction for CKD: a journey of a thousand miles.Decoy receptor 3 inhibits renal mononuclear leukocyte infiltration and apoptosis and prevents progression of IgA nephropathy in mice.Reappraisal of proteinuria and estimated GFR to predict progression to ESRD or death for hospitalized chronic kidney disease patients.Acid loading stimulates rat glomerular mesangial cells proliferation through Na(+)-H (+) exchanger isoform 1 (NHE1)-dependent pathway.Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease.
P2860
Q34281450-EEC6E632-DFEF-4113-842C-144429C1CB41Q34349235-0083751D-FEDF-49AC-8E5D-393B601C3899Q34606387-61707BEA-9B4A-45EC-B3D1-550171DF590AQ34638312-7B0BBB28-1CA1-49C3-AEBD-1B5AF85092B3Q34650709-CF47BE12-93E3-4AD0-A925-86B61A89F4AAQ34959486-8F54A845-888E-4942-BA20-639F94AA8779Q34982782-77C7A993-D920-41FB-938C-CA19687D5624Q35037033-6AEE064B-5455-4F3D-837F-265DFFBBA075Q35269939-ABF05D8B-B18F-4D1F-9280-D052AC31D4E3Q35774399-9117A5D6-1927-45C2-9F81-909EEA69D7FBQ36112117-6BA61D8B-2838-4D43-9CAE-762E25E9E429Q36443920-8C95CB5C-2B93-4AD5-A9E1-4FF07CD1753DQ36527885-210EB0DF-66FC-4BF4-973B-0043787D75D3Q36543089-B23B2D01-54E5-466F-AB05-D1AC3094D655Q36875566-56AD943C-7481-4B55-8A88-D7A0A16CB081Q36906016-52252956-BEED-47C4-A562-AE986D09C5EEQ37061210-54DD842C-7506-4E2A-A04E-E5FDD3D8CFEBQ37258096-7D05E893-22CE-4AC5-BDEC-AD6BFB1B98E3Q37362775-B59AFE74-B53F-4C8A-ACAC-399D5B3BD552Q37367740-3498F3E0-DBC5-413A-ABFE-253E0C85B676Q37437185-C01C9C3C-1446-4F37-A532-38AB0177C29BQ37588462-B7CFA10A-8F84-4D48-934C-CAE69FAE9632Q37682240-8D35B0F6-F1A1-49C2-9C94-41D477FFA8D7Q37803232-6CAAF784-A1FC-4E97-BD9B-AB42F92E7696Q37858832-A15F3AE7-56F2-4E8C-A3A4-5DC7285E9DB1Q37871572-949029D5-28A7-4799-A397-F9946DB10FA0Q38246640-F79E8E1D-64DD-4091-945E-B720AEEAF912Q38944876-F03E81FE-2B24-495A-938F-81D070887ADAQ40747225-6A262897-2492-4578-8E1E-45E82E4DFE14Q40826311-3757ACBD-A260-429D-BE5F-B827EAA46471Q42399357-4CC89301-B5E1-4ED8-BEA0-A8192728DB10Q45873053-6A959A67-44DB-4936-8AC0-18539204F1ABQ45979319-4536A8A5-D9A9-4443-8532-BFE3C7036AF7Q50235885-D50B8836-D997-415C-9CAE-C4C8C4512857Q53118344-BDEDCCFF-8BF9-490A-8AF0-799EDF8FD4C6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Renal risk scores: progress and prospects.
@en
Renal risk scores: progress and prospects.
@nl
type
label
Renal risk scores: progress and prospects.
@en
Renal risk scores: progress and prospects.
@nl
prefLabel
Renal risk scores: progress and prospects.
@en
Renal risk scores: progress and prospects.
@nl
P356
P1433
P1476
Renal risk scores: progress and prospects.
@en
P2093
P2888
P304
P356
10.1038/KI.2008.36
P407
P577
2008-03-05T00:00:00Z